Medication Guidelines

DISCLAIMER

The Florida Best Practice Medication Guidelines for the use of psychotropic medication in children, adolescents and adults reflects the state of knowledge, current at the time of publication, on effective and appropriate care, as well as clinical consensus judgment when research findings are lacking. The inevitable changes in the state of scientific information and technology mandate that periodic review, updating, and revisions will be needed. These guidelines do not apply to all patients and each must be adapted and tailored to each individual patient. Proper use, adaptation, modifications, or decisions to disregard these or other guidelines, in whole or in part, are entirely the responsibility of the clinician who uses these guidelines. The authors bear no responsibility for the use of these guidelines by third parties.

Level Framework for Best Practice Guidelines

The expert panel decided to use the existing format of the Florida Best Practice Medication Guidelines, where instead of creating an algorithm where  specific options are mandatory or had to be used first or diagrammatically looked like  they had to be used first, the panel decided to categorize options in different levels, based upon the strength of the science and expert consensus regarding a particular agent or treatment option. The panel weighed both safety and efficacy issues when  assigning a particular agent or treatment option to a level.

Level 1 options were considered to have stronger evidence and consensus
than Level 2 and below.
The panel chose this approach with an understanding that using a particular option in
any level would depend upon clinical judgment and patient or family needs or preferences.
Level 0 refers to an assessment level prior to any decision regarding treatment
options. Risk assessment changes as you go down levels.


Top ▲